Ildong Bioscience Seeks to Expand in Global Markets by Participating in 'Vita Foods Europe'
Ildong Bioscience, a health functional food affiliate of Ildong Pharmaceutical Group, announced on the 11th that it participated in the '2026 Vita Foods Europe' event, where it promoted its business capabilities and functional ingredients, seeking to expand its global presence.
'Vita Foods Europe' is the largest food, beverage, and health functional food exhibition in the European healthcare sector. This year's event was held from May 5 to 7 in Barcelona, Spain.
Booth of Ildong Bioscience, a health functional food business affiliate of Ildong Pharmaceutical Group, at the 2026 Vita Foods Europe. Ildong Pharmaceutical Group
View original imageDuring the event, Ildong Bioscience highlighted its competitiveness in the fields of probiotics and postbiotics, featuring both functional ingredients and its quadruple-coating processing technology. The company also held partnership meetings with numerous global companies, seeking to discover new partners and explore business alliances to enter overseas markets.
An official from Ildong Bioscience stated, "Our functional probiotic materials, tailored to the characteristics of the global market—including more than 20 types of ingredients with U.S. GRAS (Generally Recognized As Safe) status, and those certified as HALAL and Kosher—received considerable attention from visitors."
The official added, "In addition to the steadily performing Asian and North American markets, we are also expanding exports to European countries such as Spain and Greece. We plan to further diversify our product portfolio and expand our client base by implementing strategies tailored to each local market."
Founded in 2016, Ildong Bioscience is a health functional food company specializing in lactic acid bacteria and probiotics. The company possesses a database of over 5,000 bacterial strains as well as numerous patents and proprietary technologies, establishing strong business competitiveness.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "I Take Full Responsibility"... Chung Yongjin Issues Direct Apology for Starbucks 'May 18 Controversy' (Update)
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Based on its proprietary technology, the company has developed a variety of probiotics and postbiotics for gut health, skin immunity, cholesterol, body fat, and sleep. Leveraging its industry-leading manufacturing infrastructure, Ildong Bioscience is actively engaged in the development of functional ingredients and products, contract development and manufacturing (CDMO), and raw material supply.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.